Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Been targeted by a scam? Get free assistance from the AARP Fraud ...

The proposed offer of ¥6,082 per share represents a roughly 35% premium to Hisamitsu’s unaffected closing price on Monday.

Hisamitsu, known for its Salonpas pain-relief patches, joins a growing list of Japanese companies exiting the public market.

Hisamitsu Pharmaceutical Co. is set to climb to its daily trading limit for a second day after the Japanese maker of ...

A growing list of companies are exiting the public market to shield themselves from growing regulatory and investor pressure ...

The Japanese government has been promoting cheaper generic medicines and pushing drugmakers to cut prices as its population ...

Hisamitsu Pharmaceutical Co. is considering a takeover bid to privatize the Japanese maker of pain-relief patches in a deal ...

A new weight-loss drug that Eli Lilly is testing is helping patients in a late-stage trial lose an average of 28.7% of their body weight and offered "substantial" relief from osteoarthritis pain. In ...

In a phase 3 trial, Eli Lilly’s experimental drug retatrutide delivered an average 28.7% weight loss and reduced pain among adults with obesity or overweight and knee osteoarthritis. The trial ...

Cannabidiol (CBD) oil, derived from the cannabis plant, has recently become a popular topic in medical and scientific research circles as a non-intoxicating compound with pain-management potential.

Reaching for CBD-infused lotion or oil may seem like a low-risk way to find pain relief, but little is actually known about the impact that CBD has on the nervous system. Over the past decade, the use ...

Ice therapy involves cooling the painful area of your back. It's helpful for acute (new or temporary) back pain. While it's helpful in the short term, long-term use of ice therapy may delay healing ...